International Consortium for Innovation and Quality in Pharmaceutical Development
IQ Connect
About
Initiatives
News
Events
Publications & Comments
Join IQ
Leadership
Groups
Analytical
Drug Substance (previously API)
Biologics CMC
Clinical Pharmacology
Drug Product
Translational and ADME Sciences (TA)
Good Laboratory Practice Quality Assurance
Good Manufacturing Practice Quality Assurance
DruSafe
Statistics
3Rs Translational and Predictive Sciences
Life Sciences
Working Groups
Artificial Intelligence and Machine Learning
CPLG Regulatory Guidance Committee
Imaging MS Discussion Group
Induction
In Silico DMPK Discussion Group
In vitro Repro/Developmental Assay Predictivity
Non-Clinical to Clinical Translational Safety
Pediatrics (CPLG)
Preclinical Suicidality
CMC
Working Groups
Accelerated Drug Development
ALG Biologics
Change Management in Development
Data Integrity Working Group
Dissolution Working Group
Drug Substance Continuous Manufacturing
Green Chemistry
In-Use Microbial Stability
Injectable Products Allowable Content Working Group
Novel Excipients
PAT
Pediatric (DPLG)
Physicochemical in-use WG
Quality Risk Management
Cross-Disciplinary
Working Groups
3Rs COVID-19
3Rs CRO Outreach
3Rs NHP Reuse
3Rs Nonhuman Primate Husbandry
3Rs Recovery Animals
3Rs Reproducibility
Implementation of ICHQ10
Archived Groups
Back to News
Interested in novel modalities and development strategies?
August 17, 2022
